Communications Medicine
A selective open access journal from Nature Portfolio publishing high-quality research, reviews and commentary across all clinical, translational, and public health research fields.
Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting
Little is known about the impact of antiviral treatments on biomarkers of COVID-19 severity. Here, we measured biomarkers during the course of COVID-19 in high-risk non-hospitalized patients treated with or without the antiviral remdesivir.